Raphael Pharmaceutical Inc. Comprehensive Income
Raphael Pharmaceutical Inc. (RAPH) reported Comprehensive Income of $3.36 million for the 12-month period ending 2022-12-31, per its 10-K/A filed 2023-05-25.
Discontinued › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2023-05-25
- Raphael Pharmaceutical Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $3.36M, a 106.65% increase from fiscal 2021.
- Raphael Pharmaceutical Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was $1.63M.
- Raphael Pharmaceutical Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$718.00K.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|
| 2022-12-31 | $3.36M 10-K/A · filed 2023-05-25 | |
| 2021-12-31 | $1.63M 10-K/A · filed 2023-05-25 | -$1.63M 10-K · filed 2022-03-30 |
| 2020-12-31 | -$718.00K 10-K · filed 2022-03-30 |